{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Eli Lilly", "item": "https://www.patentleaderboard.com/company/lilly"}, {"@type": "ListItem", "position": 3, "name": "Thomas Combs IRVIN", "item": "https://www.patentleaderboard.com/inventor/fl:th_ln:irvin-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
TI

Thomas Combs IRVIN — 7 Patents

Eli Lilly: 4 patents #827 of 2,858Top 30%
Erie, CO: #99 of 421 inventorsTop 25%
Colorado: #6,721 of 40,980 inventorsTop 20%
Overall (All Time): #680,018 of 4,157,543Top 20%
7 Patents All Time
Thomas Combs IRVIN has been granted 7 US patents while listed as an inventor at Eli Lilly. The first was granted in 2023 and the most recent in April 2024. Thomas Combs IRVIN ranks #680,018 of 4,157,543 US inventors in our database (top 16.4%). Patent records list Thomas Combs IRVIN in Erie, CO, US.

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11970485 RET kinase inhibitors Gabrielle R. Kolakowski, Erin Danielle ANDERSON, Steven W. Andrews, Christopher Pierre Albert Jean Boldron, Kevin Ronald Condroski +9 more 2024-04-30 $5,266,524,000
11964968 Compounds useful for inhibiting RET kinase Erin Danielle ANDERSON, Steven W. Andrews, Kevin Ronald Condroski, Gabrielle R. Kolakowski, Manoj KUMAR +4 more 2024-04-23 $4,797,509,000
11878970 Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease Erin Danielle ANDERSON, Sean Aronow, Nicholas Boyles, Xiaohong Chen, Surendra DAWADI +12 more 2024-01-23
11873295 Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease Erin Danielle ANDERSON, Sean Aronow, Nicholas Boyles, Surendra DAWADI, Eugene Richard Hickey +13 more 2024-01-16
11697647 RET kinase inhibitors Gabrielle R. Kolakowski, Erin Danielle ANDERSON, Steven W. Andrews, Christopher Pierre Albert Jean Boldron, Kevin Ronald Condroski +9 more 2023-07-11 $2,453,433,000
11649227 Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease Erin Danielle ANDERSON, Sean Aronow, Nicholas Boyles, Markus Dahlgren, Shulu FENG +16 more 2023-05-16
11613533 Compounds useful for inhibiting RET kinase Erin Danielle ANDERSON, Steven W. Andrews, Kevin Ronald Condroski, Gabrielle R. Kolakowski, Manoj KUMAR +4 more 2023-03-28 $1,082,597,000